Client Alert – Medicare Fraud Strike Force Nabs Eight in $100 Million Compounding Scheme

November 8th, 2017|FisherBroyles News, Health Care, Pharmacy Law|

Seven defendants have pleaded guilty to conspiracy to commit health care fraud and, while awaiting sentencing, have watched the government seize a number of expensive toys, including a 1936 Ford Deluxe, a 1964 Chevrolet Corvette [...]

FisherBroyles Welcomes New Patent Partner to its Denver Office

November 7th, 2017|FisherBroyles News, Intellectual Property|

FisherBroyles, LLP is pleased to welcome Rita S. Wu, Ph.D., J.D. as a partner in the firm. Dr. Wu uses her academic background, that includes a PhD in microbiology and immunology, as well as clinical [...]

Real Estate Partner, Daniel Weidenbruch, Recognized by Peers and Featured in the 24th Edition of The Best Lawyers in America

November 7th, 2017|FisherBroyles News|

Real Estate Partner, Daniel Weidenbruch, recognized by peers and featured in the 24th Edition of The Best Lawyers in America for his high caliber work in Real Estate Law.

Employment and Litigation Partner Amy Epstein Gluck Talks with Business Insurance about Reducing Sexual Harassment in the C-Suite

November 7th, 2017|FisherBroyles News|

Employment and litigation partner Amy Epstein Gluck talks with Business Insurance about key factors to reducing sexual harassment in the C-Suite.

Client Alert – AmerisourceBergen Earnings Report Discloses $575 Million Set Aside For FCA Settlement

November 7th, 2017|FisherBroyles News, Health Care|

In late September 2017, drug wholesaler AmerisourceBergen Corp. (ASBG) pleaded guilty in federal court in Brooklyn to violations of the federal Food, Drug and Cosmetic Act in the sale of misbranded oncology drugs. The guilty [...]

Client Alert: FDA Issues Warning to Four Companies Marketing Cannabidiol-Containing Products as Anti-Cancer Treatment

November 6th, 2017|FisherBroyles News, Pharmacy Law|

On November 1, 2017, the U.S. Food and Drug Administration issued warning letters to four companies that were illegally marketing and selling products online that the companies misrepresented as having benefits in the prevention or [...]